Operating Margin

102.1%
Current
Improving
by 1.3%
vs 3-y average of 100.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
102.1%
=
Operating Income
kr-422.8m
/
Revenue
kr-414m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
102.1%
=
Operating Income
kr-422.8m
/
Revenue
kr-414m

Peer Comparison

Country Company Market Cap Operating
Margin
SE
Linc AB
STO:LINC
3.7B SEK
Loading...
US
BlackRock Inc
NYSE:BLK
163.9B USD
Loading...
US
Blackstone Inc
NYSE:BX
154.3B USD
Loading...
CA
Brookfield Corp
NYSE:BN
99.4B USD
Loading...
ZA
Ninety One Ltd
JSE:NY1
93.6B ZAR
Loading...
US
KKR & Co Inc
NYSE:KKR
88.6B USD
Loading...
US
Bank of New York Mellon Corp
NYSE:BK
82.8B USD
Loading...
CA
Brookfield Asset Management Inc
NYSE:BAM
78.4B USD
Loading...
CA
BROOKFIELD ASSET MANAGEMENT LTD
TSX:BAM
107.3B CAD
Loading...
US
BROOKFIELD ASSET MANAGEMENT LTD
F:RW5
66.1B EUR
Loading...
US
Ameriprise Financial Inc
NYSE:AMP
48.8B USD
Loading...

Market Distribution

Higher than 98% of companies in Sweden
Percentile
98th
Based on 2 047 companies
98th percentile
102.1%
Low
-2 025 693.8% — -1.8%
Typical Range
-1.8% — 12.5%
High
12.5% — 10 459.2%
Distribution Statistics
Sweden
Min -2 025 693.8%
30th Percentile -1.8%
Median 6%
70th Percentile 12.5%
Max 10 459.2%

Linc AB
Glance View

Market Cap
3.7B SEK
Industry
Financial Services

Linc AB is an investment company that focuses on long-term share ownership in the Nordic life science market. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2021-05-28. Linc invests in product-oriented companies within the Nordic Life Science industry - primarily in pharmaceutical and medical technology companies. The investments are made in both private and public companies and in research and operational companies. Typically, investments in drug development take place in an earlier phase compared to investments in medical technology. Linc Invest is an active and long-term owner with a wide industrial network to support the portfolio companies. The firm works together with the management, founders and board to realize the inherent potential that exists in the investment, have ambitious plans for further development and expansion and actively participate in the nomination committee work.

LINC Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
102.1%
=
Operating Income
kr-422.8m
/
Revenue
kr-414m
What is Linc AB's current Operating Margin?

The current Operating Margin for Linc AB is 102.1%, which is above its 3-year median of 100.8%.

How has Operating Margin changed over time?

Over the last 3 years, Linc AB’s Operating Margin has increased from 100.7% to 102.1%. During this period, it reached a low of 93.1% on Mar 31, 2025 and a high of 117.5% on Sep 30, 2025.

Back to Top